The diabetic injection Ozempic, with semaglutide, halves severe heart failure symptoms, heralding a groundbreaking leap in heart failure management.
Scientists have found that microplastics present inside arterial plaque are a new factor leading to cardiovascular risk, and those who have it are at 2.1 times higher risk than those who do not.